Tech Alabama stopped by the SynVivo offices recently to interview president and CEO, Richard Piazza for his views on the technology and its application to the future of cancer treatment. Check out the “5 questions with SynVivo president and CEO C. Richard Piazza” article where he discusses his background and why he joined SynVivo, how the SynVivo chip could help change cancer drug treatment, plans for growth, and how SynVivo is trying to change the way cancer patients are treated.
See a newscast snippet about the interview here.
SynVivo, Inc is a subsidiary of CFDRC
Learn more at www.synvivobio.com
